Cargando…

Primary Ovarian Insufficiency in Women With Addison’s Disease

CONTEXT: Primary ovarian insufficiency (POI) is defined by menopause before 40 years of age. POI prevalence is higher among women with autoimmune Addison’s disease (AAD) than in the general population, but their clinical characteristics are insufficiently studied. OBJECTIVE: To assess the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogt, Elinor C, Breivik, Lars, Røyrvik, Ellen C, Grytaas, Marianne, Husebye, Eystein S, Øksnes, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208662/ https://www.ncbi.nlm.nih.gov/pubmed/33686417 http://dx.doi.org/10.1210/clinem/dgab140

Ejemplares similares

The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease
por: Wolff, Anette Boe, et al.
Publicado: (2021)

THU630 Improving Diagnostic Precision In Primary Ovarian Insufficiency Using Comprehensive Genetic And Autoantibody Testing
por: Vogt, Elinor, et al.
Publicado: (2023)

FRI421 Immunomodulatory Therapy Can Improve Fertility In Women With Autoimmune Premature Ovarian Insufficiency - A Proof Of Concept Study
por: Hirschberg, Angelica Linden, et al.
Publicado: (2023)

21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules
por: Hellesen, Alexander, et al.
Publicado: (2021)

Sex-Specific Limitations in Physical Health in Primary Adrenal Insufficiency
por: Didriksen, Nora Møller, et al.
Publicado: (2021)

SAT296 Ambulatory 24-hour Tissue Microdialysis Of Cortisol And Metabolites, A Tool For Precision Management In Addison’s Disease
por: Botusan, Ileana, et al.
Publicado: (2023)

Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2021)

GWAS for autoimmune Addison’s disease identifies multiple risk loci and highlights AIRE in disease susceptibility
por: Eriksson, Daniel, et al.
Publicado: (2021)

Residual Corticosteroid Production in Autoimmune Addison Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2020)

Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines
por: Edvardsen, Kine, et al.
Publicado: (2015)

Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts
por: Vogt, Elinor Chelsom, et al.
Publicado: (2022)

Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism
por: Grytaas, Marianne Aa, et al.
Publicado: (2018)

Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison’s disease
por: Edvardsen, Kine, et al.
Publicado: (2016)

Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019)

Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease
por: Brønstad, Ingeborg, et al.
Publicado: (2011)

Autoimmune Thyroid Disorders in Autoimmune Addison Disease
por: Meling Stokland, Ann-Elin, et al.
Publicado: (2022)

SAT285 Biomarkers For Cardiovascular Disease And Inflammation Are Altered In Autoimmune Addison's Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2023)

Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function
por: Åkerman, Anna-Karin, et al.
Publicado: (2023)

Multisteroid LC–MS/MS assay for glucocorticoids and androgens and its application in Addison's disease
por: Methlie, Paal, et al.
Publicado: (2013)

OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
por: Aardal Grytaas, Marianne, et al.
Publicado: (2023)

Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019)

OR30-03 High Resolution Daily Profiles Of Tissue Adrenal Steroids By Portable Automated Collection
por: Upton, Thomas, et al.
Publicado: (2023)

A Variant in the BACH2 Gene Is Associated With Susceptibility to Autoimmune Addison's Disease in Humans
por: Pazderska, Agnieszka, et al.
Publicado: (2016)

Suprarenal Extract in Addison's Disease
Publicado: (1905)

A Case of Addison's Disease
por: Prichard, James E.
Publicado: (1885)

Treatment of Addison's Disease
Publicado: (1903)

Primary Adrenal Insufficiency (Addison's Disease) Associated with Systemic Lupus Erythematosus: A Rare Occurrence
por: Godswill, Okwuonu Chimezie, et al.
Publicado: (2014)

Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
por: Mitchell, Anna L., et al.
Publicado: (2015)

Correction: Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
por: Mitchell, Anna L., et al.
Publicado: (2015)

Addison's Anæmia
Publicado: (1902)

POLR2C Mutations Are Associated With Primary Ovarian Insufficiency in Women
por: Moriwaki, Mika, et al.
Publicado: (2017)

Primary adrenal lymphoma as a cause of adrenal insufficiency, a report of two cases
por: Grønning, Kaja, et al.
Publicado: (2020)

Eosinophilia in Addison's disease.
por: Spry, C.
Publicado: (1976)

The Treatment of Addison's Disease
por: Rolland, C. F.
Publicado: (1952)

Assessment of diabetic polyneuropathy in Zanzibar: Comparison between traditional methods and an automated point-of-care nerve conduction device
por: Vogt, Elinor C., et al.
Publicado: (2017)

Addison's disease
por: Sarkar, Soumya Brata, et al.
Publicado: (2012)

Addison's Disease
Publicado: (1890)

Addison’s Disease
por: Rochester, Thos. F.
Publicado: (1880)

Addison’s Disease
por: Rochester, Thos. F.
Publicado: (1880)

Addison’s Disease
Publicado: (1883)

Cannot write session to /tmp/vufind_sessions/sess_l1mtd6nqn9icb022111m3l34hb